Skip to main content
STADA Arzneimittel AG logo

STADA Arzneimittel AG — Investor Relations & Filings

Ticker · SAZ ISIN · DE0007251803 LEI · 529900FMTTLMH0P0DL10 HM Manufacturing
Filings indexed 916 across all filing types
Latest filing 2015-05-08 Interim / Quarterly Rep…
Country DE Germany
Listing HM SAZ

About STADA Arzneimittel AG

https://www.stada.com/

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Recent filings

Filing Released Lang Actions
Q1 Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT ON THE FIRST THREE MONTHS 2015' and contains detailed financial tables, key figures, and a 'CONSOLIDATED INTERIM MANAGEMENT REPORT'. It provides substantive financial data and analysis for a period shorter than a full fiscal year (Q1 2015), which aligns perfectly with the definition of an Interim/Quarterly Report (IR). Q1 2015
2015-05-08 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly states the total number of voting rights as of April 30, 2015, referencing Article 26a of the WpHG (German Securities Trading Act). This type of announcement, which reports on the total number of shares carrying voting rights, directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is a short announcement, its specific content about voting rights makes DVA a better fit than the general RPA or RNS.
2015-04-30 English
Declaration of Voting Results & Voting Rights Announcements 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states in the title and content that it is a 'Voting Rights Announcement' concerning the exceeding of a threshold (5%) of voting rights in STADA Arzneimittel AG, referencing Article 26, Section 1 of the WpHG. This directly matches the definition for 'Declaration of Voting Results & Voting Rights Announcements' (Code: DVA). The document is short and is a direct announcement, not a presentation or a full report.
2015-04-30 English
STADA Arzneimittel Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 03.06.2015 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 99% confidence The document is explicitly titled 'Einladung zur ordentlichen Hauptversammlung 2015' (Invitation to the Annual General Meeting 2015) and details the agenda, location, date (June 3, 2015), and procedures for shareholder participation and voting. The content directly relates to the convening of the Annual General Meeting (AGM). This aligns perfectly with the definition for AGM Information (AGM-R). Although it contains references to the Annual Report (Jahresabschluss) under Agenda Item 1, the primary purpose and nature of this specific document is the formal invitation and announcement of the meeting itself.
2015-04-23 German
Correction of the Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'STADA Arzneimittel AG: Correction of the Release according to Article 26a of the WpHG' and explicitly states it is a 'Total Voting Rights Announcement'. It reports the total number of voting rights as of the end of March 2015. This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers announcements related to voting rights.
2015-04-01 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (1295 characters) and explicitly states it is a 'Total Voting Rights Announcement' according to Article 26a of the WpHG. It reports the total number of voting rights as of March 31, 2015. This type of announcement, which reports on the total number of shares/votes outstanding, is a specific regulatory disclosure. Among the provided definitions, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most appropriate fit, as it deals directly with voting rights figures, even if it's not the result of a specific vote, but rather the total outstanding rights.
2015-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.